8-K: Kimberly-Clark Reports Strong Q2 2025 Results, Raises Full-Year Outlook

Kimberly-Clark announced robust second quarter 2025 results, driven by innovation-led volume growth and effective cost management, leading to an upward revision of its full-year outlook.

Summary

• Net sales for Q2 2025 were $4.2 billion, a 1.6% decrease year-over-year, primarily due to divestitures and unfavorable currency translation.
• Organic sales grew by 3.9% in Q2 2025, fueled by a 5.0% increase in volume, partially offset by 1.2% price investments.
• Reported diluted earnings per share (EPS) were $1.53, down from $1.61 in the prior year, while adjusted EPS decreased 2.0% to $1.92.
• Adjusted gross margin was 36.9% in Q2 2025, a decrease of 180 basis points compared to the prior year, reflecting planned investments in price:value tiers and incremental tariff-driven costs.
• Adjusted operating profit for Q2 2025 was $713 million, down 2.2% year-over-year.
• North America segment organic sales increased 4.3%, driven by 5.2% volume growth, with Personal Care categories gaining 60 basis points in weighted share.
• International Personal Care segment organic sales increased 3.3%, driven by 4.8% volume growth.
• Year-to-date cash provided by operations was $1.1 billion, down from $1.5 billion in the prior year.
• The company returned $944 million to shareholders through dividends and common stock repurchases year-to-date.
• Total debt decreased to $7.2 billion as of June 30, 2025, from $7.4 billion at December 31, 2024.

Sentiment

Score: 8

Explanation: The filing indicates strong operational performance with significant organic sales and volume growth, leading to a raised full-year outlook. While reported net sales and EPS were down due to divestitures and currency, the underlying business health, driven by innovation and market share gains, is positive. The reduction in debt and return of capital to shareholders also contribute to a strong sentiment.

Positives

• Organic sales grew 3.9% in Q2 2025, driven by 5.0% volume growth, which is the highest volume growth achieved in five years.
• North America organic sales increased 4.3%, with Personal Care categories gaining 60 basis points in weighted market share.
• International Personal Care organic sales increased 3.3%, demonstrating improved value propositions.
• The full-year 2025 outlook for Organic Sales Growth, Adjusted Operating Profit, and Adjusted Earnings per Share Attributable to Kimberly-Clark has been raised.
• The company expects 2025 Organic Sales Growth to outpace the weighted average category growth of approximately two percent.
• Adjusted Free Cash Flow is expected to be approximately $2 billion in 2025.
• Total debt decreased to $7.2 billion as of June 30, 2025, from $7.4 billion at December 31, 2024.
• Returned $944 million to shareholders through dividends and share repurchases year-to-date.

Negatives

• Net sales decreased 1.6% in Q2 2025 to $4.2 billion, primarily due to divestitures and unfavorable currency translation.
• Reported diluted EPS decreased to $1.53 in Q2 2025 from $1.61 in the prior year.
• Adjusted diluted EPS decreased 2.0% to $1.92 in Q2 2025.
• Adjusted gross margin was down 180 basis points to 36.9% in Q2 2025, impacted by unfavorable pricing net of cost inflation and incremental tariff-driven costs.
• Adjusted operating profit decreased 2.2% to $713 million in Q2 2025.
• Year-to-date cash provided by operations decreased to $1.1 billion from $1.5 billion in the prior year.
• Income from discontinued operations, net of income taxes, decreased to $68 million in Q2 2025 from $89 million in the prior year, partly due to pre-tax separation costs of $33 million.

Risks

• Fluctuations in raw material, energy, and other input costs.
• Risks related to delays or failure to complete the pending International Family Care and Professional (IFP) joint venture transaction with Suzano.
• Incurrence of significant transaction and separation costs related to the IFP transaction.
• Adverse market reactions, regulatory or legal challenges, and operational disruptions related to the IFP transaction.
• Risks of not realizing the anticipated benefits of the 2024 Transformation Initiative, including disruptions to business or operations or delays in implementation.
• Impacts from the war in Ukraine, including responses of consumers, customers, suppliers, and sanctions.
• Government trade or similar regulatory actions, including current and potential trade and tariff actions affecting operating countries, and resulting negative impacts on supply chain, commodity costs, and consumer spending.
• Impacts from pandemics and epidemics.
• Fluctuations in foreign currency exchange rates, including impacts in Argentina and Türkiye.
• Prices and availability of raw materials.
• Supply chain disruptions.
• Disruptions in the capital and credit markets.
• Counterparty defaults (customers, suppliers, financial institutions).
• Failure to realize expected benefits or synergies from acquisition and disposition activity.
• Impairment of goodwill and intangible assets.
• Changes in customer preferences.
• Severe weather conditions.
• Regional instabilities and hostilities, including the war in Israel.
• Potential competitive pressures on selling prices for products.
• Energy costs.
• General economic and political conditions globally and in markets where the company operates.
• Ability to maintain key customer relationships.
• Other factors not presently known or considered immaterial could also affect business operations and financial results.

Future Outlook

Kimberly-Clark adjusted its full-year 2025 outlook, expecting Organic Sales Growth to outpace the weighted average growth in its categories and countries, which is currently around two percent. Adjusted Operating Profit and Adjusted Earnings per Share Attributable to Kimberly-Clark are both forecast to grow at a low-to-mid single digit rate on a constant-currency basis. Adjusted Free Cash Flow is projected to be approximately $2 billion. The outlook reflects negative impacts from currency translation and the PPE divestiture/private label diaper business exit.

Management Comments

• Our second quarter results are indicative of the exceptional progress we are making executing our Powering Care strategy.
• This was a very active quarter and one of the strongest in our recent history. We delivered strong organic sales growth, fueled by the highest volume growth weve achieved in five years.
• Our durable brands, differentiated value propositions and innovation investments enabled us to enhance and maintain leading market share positions across categories and price tiers.
• We took decisive actions to set Kimberly-Clark up for enhanced, sustainable growth and profitability.
• Our strategy comes to life through our peopleIm proud of how our team continues to perform as we transform. Despite a dynamic operating environment, we are well-positioned to deliver a strong second year of our transformation.

Industry Context

Kimberly-Clark's strong organic sales and volume growth, particularly in North America and International Personal Care, suggest effective navigation of a dynamic operating environment. The focus on innovation and improving price:value tiers aligns with broader consumer goods trends where companies are balancing premiumization with affordability amidst inflationary pressures and evolving consumer preferences. The divestiture of non-core businesses like PPE and private label diapers indicates a strategic focus on core, higher-margin categories, a common industry move to streamline operations and enhance profitability.

Comparison to Industry Standards

• The filing states that 2025 Organic Sales Growth is expected to outpace the weighted average growth in the categories and countries it competes, which are currently growing at approximately two percent. This implies outperformance relative to its direct market segments.

Stakeholder Impact

• Shareholders: Positive impact due to strong organic growth, raised outlook, debt reduction, and return of capital through dividends and share repurchases. Potential for increased value from the "Powering Care" transformation.
• Employees: Positive impact from the ongoing "Powering Care" transformation, with management expressing pride in team performance, suggesting stability and strategic focus.
• Customers: Positive impact from innovation-led volume growth and improved value propositions across the portfolio, enhancing product offerings and market share.
• Suppliers: Potential for continued business as the company focuses on productivity gains and manages supply chain dynamics, though tariff-related costs could influence sourcing decisions.
• Creditors: Positive impact from reduced total debt, indicating improved financial stability and ability to meet obligations.

Next Steps

• Continue execution of the "Powering Care" transformation strategy.
• Complete the joint venture transaction with Suzano for the International Family Care and Professional (IFP) business, anticipated mid-year 2026.
• Host a live Q&A session with investors and analysts on August 1, 2025.

Key Dates

Recommendation

The filing reveals robust underlying business performance, highlighted by strong organic sales growth and the highest volume growth in five years, indicating effective strategic execution. The company's decision to raise its full-year outlook for key metrics like organic sales, adjusted operating profit, and adjusted EPS signals management confidence and positive future prospects. Despite some reported declines due to strategic divestitures and currency headwinds, the core business is demonstrating resilience and market share gains in key categories. The reduction in debt and consistent return of capital to shareholders further strengthen the investment thesis, suggesting a company well-positioned for sustainable growth and value creation.

Keywords

Kimberly-Clark, KMB, Consumer Goods, Personal Care, Diapers, Wipes, Tissue, Huggies, Kleenex, Scott, Kotex, Earnings, Financial Results, Q2 2025, Outlook, Organic Sales, Volume Growth, Transformation Initiative, SEC Filing, 8-K